ArticleBMC psychology2022
The Monkeypox Fear Scale: development and initial validation in a Peruvian sample.
Article in BMC psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Navigating the fear: assessing nursing students' concerns and preventive practices in response to Monkeypox in Egypt.BMC nursing · 2025Article
- Review
- A Systematic Review on the Mental Health Status of Patients Infected With Monkeypox Virus.Journal of the Korean Academy of Child and Adolescent Psychiatry · 2024Review
- Intention to receive the monkeypox vaccine and its psychological and sociodemographic predictors: a cross-sectional survey in the general population of Peru.Psicologia, reflexao e critica : revista semestral do Departamento de Psicologia da UFRGS · 2023Article
- The Chikungunya anxiety scale (CHIKAS): Development, validation, and relationship between its items and illness-related factors.Industrial psychiatry journal · 2023Article
- Validity and Reliability of the Knowledge, Attitudes and Practices Instrument Regarding Monkey Pox in Peru.Risk management and healthcare policy · 2023Article
- The Dengue Anxiety Scale (DENAS): A new tool for assessing disease-specific anxiety.Industrial psychiatry journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFear is one of the basic emotions generated during periods of infectious diseases. Therefore, the aim of this study was to develop and validate a scale that assesses monkeypox fear, the Monkeypox Fear Scale (MFS).
methodsA total of 451 Peruvians participated (61% women and 39% men), with a mean age of 28.31 years (SD = 9.72). based on procedures from classical test theory (CTT) and item response theory (IRT). Classical Test Theory (CTT) and Item Response Theory (IRT) procedures were used.
resultsThe results showed that MFS has a two-factor structure related to emotional and physiological fear factors (χ2 = 41.87; df = 12; p < .001; CFI = .99; TLI = .99; RMSEA = .074 [IC90% .051-.100]). In addition, the physiological and emotional factors showed good reliability. Measurement invariance analysis showed that the factor structure of the MFS is strictly invariant between male and female groups. Finally, the discrimination and difficulty parameters of the items show adequacy. In addition, the scale seems to be more accurate in measuring high levels of fear of monkeypox.
conclusionThe MFS has adequate psychometric evidence to assess fear of monkeypox in the Peruvian population. These findings may guide future studies related to the consequences of monkeypox on mental health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.